Let’s Talk

Adamax (10mg Vial) Dosage Protocol

Contents

Compound Overview

Chemical Structure & Properties

Origin, Derivation & Development

Mechanism of Action

Potential Benefits & Observed Outcomes

Safety, Side Effects & Risk Considerations

Research Status, Legal & Compliance Context

Handling, Stability & Technical Notes

Certificate of Analysis

References

Recommended Sellers

Compound Overview

Adamax is an adamantane‑modified analog of Semax (N‑acetyl Semax Amidate), a heptapeptide derivative of ACTH(4–10) studied for nootropic and neuroprotective properties[1][2]. The adamantane moiety enhances blood–brain barrier penetration and peptide stability, yielding greater potency than standard Semax[3]. This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

  • Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
  • Typical daily range: 500–1000 µg once daily (gradual titration).
  • Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 µg on a U‑100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 1–2 weeks; avoid freeze–thaw cycles.

Chemical Structure & Properties

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

Week Daily Dose Units (per injection) (mL)
Weeks 1–2 300 µg (0.3 mg) 9 units (0.09 mL)
Weeks 3–4 500 µg (0.5 mg) 15 units (0.15 mL)
Weeks 5–6 750 µg (0.75 mg) 23 units (0.23 mL)
Weeks 7–8 1000 µg (1.0 mg) 30 units (0.30 mL)

Frequency: Inject once daily subcutaneously. This schedule uses the largest practical dilution (3.0 mL) to keep per‑injection units readable. For the 300 µg starting dose (9 units = 0.09 mL), consider using 30‑ or 50‑unit insulin syringes for improved readability.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall to avoid foaming.
  3. Gently swirl or roll the vial until powder fully dissolves (do not shake vigorously).
  4. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Origin, Derivation & Development

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

  • Peptide Vials (Adamax, 10 mg each):
    • 8 weeks (gradual dosing): 4 vials (total ~35.7 mg used)
    • 12 weeks (gradual dosing): 7 vials (total ~60.2 mg used)
    • 16 weeks (gradual dosing): 9 vials (total ~88.2 mg used)
  • Insulin Syringes (U‑100):
    • Per week: 7 syringes (1/day)
    • 8 weeks: 56 syringes
    • 12 weeks: 84 syringes
    • 16 weeks: 112 syringes

    Note: For Week 1–2 dosing (9 units), consider 30‑unit or 50‑unit syringes for easier measurement precision.

  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
    • 8 weeks (4 vials): 12 mL → 2 × 10 mL bottles
    • 12 weeks (7 vials): 21 mL → 3 × 10 mL bottles
    • 16 weeks (9 vials): 27 mL → 3 × 10 mL bottles
  • Alcohol Swabs: One for the vial stopper + one for the injection site each day.
    • Per week: 14 swabs (2/day)
    • 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
    • 12 weeks: 168 swabs → recommend 2 × 100‑count boxes
    • 16 weeks: 224 swabs → recommend 3 × 100‑count boxes

Mechanism of Action

 Protocol Overview

Concise summary of the once‑daily regimen.

  • Goal: Support cognitive enhancement, neuroprotection, and neuroplasticity via BDNF upregulation[4][5].
  • Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired), followed by an equal off‑cycle period.
  • Dose Range: 300–1000 µg daily with gradual titration (500 µg is typical mid‑range).
  • Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

 Dosing Protocol

Suggested daily titration approach.

  • Start: 300 µg daily for 2 weeks (Week 1–2); allows adaptation to peptide effects.
  • Increase: 500 µg daily (Week 3–4), then 750 µg (Week 5–6).
  • Maintenance: 1000 µg daily (Week 7+) for continued nootropic support.
  • Frequency: Once per day (subcutaneous), preferably morning for consistency.
  • Cycle Length: 8–12 weeks; optional extension to 16 weeks with careful monitoring.
  • Off‑Cycle: Equal duration break (e.g., 8 weeks on, 8 weeks off) to prevent tolerance.

 Storage Instructions

Proper storage preserves peptide quality and potency.

  • Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; keep in original packaging to minimize moisture exposure.
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 1–2 weeks for optimal potency.
  • Avoid Freeze–Thaw: Do not refreeze reconstituted solution; freeze–thaw cycles denature peptides.
  • Allow lyophilized vials to reach room temperature before opening to reduce condensation.

Potential Benefits & Observed Outcomes

Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes for each injection; dispose in a sharps container.
  • Rotate injection sites (abdomen, thighs, upper arms) daily to reduce local irritation and lipohypertrophy.
  • Inject slowly and steadily; wait a few seconds before withdrawing the needle to prevent leakage.
  • Document daily dose, injection site, and any subjective effects (cognition, mood, sleep) to track response.
  • For doses under 10 units (Week 1–2: 9 units), consider 30‑ or 50‑unit insulin syringes for better precision.

Safety, Side Effects & Risk Considerations

How This Works

Adamax is structurally derived from Semax, a well‑studied ACTH(4–10) analog with nootropic properties. Semax increases brain‑derived neurotrophic factor (BDNF) expression and enhances TrkB receptor sensitivity in the hippocampus[4][5], promoting neuroplasticity, synaptic formation, and neuronal survival. The peptide modulates neurotransmitter systems (dopamine, serotonin) and activates intracellular signaling cascades (cAMP/CREB pathways), leading to improved memory, learning, and stress resilience[6]. Adamax’s adamantane moiety confers greater lipophilicity and enzymatic stability than Semax[3], enabling more efficient blood–brain barrier crossing and prolonged in vivo half‑life. This structural enhancement amplifies neuroprotective effects and reduces dosing frequency requirements. Preclinical data suggest 2–3 times greater efficacy in cognitive and endurance outcomes compared to standard Semax[3].

Research Status, Legal & Compliance Context

Potential Benefits & Side Effects

Observations from preclinical literature and Semax clinical studies.

Potential Benefits

  • Enhanced cognitive function: improved learning, memory consolidation, and mental clarity[4][7].
  • Neuroprotection: supports neuronal survival and recovery in ischemic or oxidative stress models[8].
  • Mood support: modulates dopamine and serotonin systems, potentially improving stress resilience and reducing anxiety[6].
  • Neuroplasticity: increases BDNF levels, promoting synaptic growth and neural connectivity[5].

Potential Side Effects

  • Generally well tolerated in Semax studies; no major adverse effects reported in short‑term human trials[9].
  • Mild injection‑site reactions (redness, itching, minor discomfort) may occur with subcutaneous administration.
  • Limited long‑term human data on Adamax specifically; extrapolated safety from Semax clinical use.
  • No significant IGF‑1 elevation or metabolic disruption observed with Semax‑class peptides[9].

Handling, Stability & Technical Notes

Lifestyle Factors

Complementary strategies for optimizing nootropic outcomes.

  • Pair with a nutrient‑dense diet rich in omega‑3 fatty acids, antioxidants, and B vitamins to support brain health.
  • Engage in regular aerobic exercise and resistance training to enhance BDNF expression synergistically.
  • Prioritize consistent sleep (7–9 hours nightly) for memory consolidation and neural recovery.
  • Practice stress management techniques (meditation, breathwork) to maximize cognitive benefits.
  • Avoid excessive alcohol and processed foods, which may impair neuroplasticity pathways.

Certificate of Analysis

Injection Technique

General subcutaneous guidance from clinical best‑practice resources[10][11].

  • Clean the vial stopper with an alcohol swab and allow to dry (~10 seconds).
  • Draw the calculated dose into a sterile insulin syringe; remove air bubbles by gently tapping the syringe.
  • Clean the injection site (abdomen, thigh, or upper arm) with a fresh alcohol swab; allow to dry.
  • Pinch a fold of skin (~1 inch) between thumb and forefinger to elevate subcutaneous tissue.
  • Insert the needle at 45–90° into the skinfold[10]; inject slowly and steadily (do not aspirate).
  • Withdraw the needle and apply gentle pressure with a clean gauze pad; do not massage the site aggressively.
  • Rotate injection sites systematically to prevent lipohypertrophy and ensure consistent absorption[12].

References

No data was found
Scroll to Top
Facebook X-twitter Youtube

Have Project?

[email protected]

Want to Work With Me

Send Brief

Want to Buy Books?

Go to Shop
+1 800 355 55 65
[email protected]